ad image

Agilent Technologies

1 / 1
How can pharmaceutical and biopharmaceutical companies demonstrate their commitment to ESG principles in manufacturing?
Commitment to ESG Principles

How can pharmaceutical and biopharmaceutical companies demonstrate their commitment to ESG principles in manufacturing?

Pharma's Almanac

PAO-03-24-CL-03Mar 08, 2024
What strategies are being employed to accelerate product development and commercialization without compromising quality?
Accelerating Product Development

What strategies are being employed to accelerate product development and commercialization without compromising quality?

Pharma's Almanac

PAO-03-24-CL-02Mar 08, 2024
What do you see as the most significant regulatory decision or guidance on the horizon for 2024 (or beyond)?
Roundtable

What do you see as the most significant regulatory decision or guidance on the horizon for 2024 (or beyond)?

Pharma's Almanac

PAO-12-23-RT-02Dec 15, 2023
What Do You Think Was The Single Most Consequential Event Or Result In Pharma/Biopharma In 2023?
Roundtable

What Do You Think Was The Single Most Consequential Event Or Result In Pharma/Biopharma In 2023?

Pharma's Almanac

PAO-12-23-RT-01Dec 14, 2023
In what international markets do you anticipate significant developments in the near future?
International Markets

In what international markets do you anticipate significant developments in the near future?

Pharma's Almanac

PAO-01-23-RT-02Jan 31, 2023
What do you view as the most disruptive or transformational technology or development on the horizon?
Disruptive Technology

What do you view as the most disruptive or transformational technology or development on the horizon?

Pharma's Almanac

PAO-01-23-RT-01Jan 31, 2023
What key indicators do you look at to predict the future of this industry?
Future of the Industry

What key indicators do you look at to predict the future of this industry?

Pharma's Almanac

PAO-10-022--RT-02Oct 11, 2022
What is your plan to build a more sustainable business practice in the coming years?
Sustainability

What is your plan to build a more sustainable business practice in the coming years?

Pharma's Almanac

PAO-10-022--RT-01Oct 11, 2022
In which orphan spaces or unmet medical needs do you think we will see the next treatment innovations?
Unmet Needs

In which orphan spaces or unmet medical needs do you think we will see the next treatment innovations?

Pharma's Almanac

PAO-06-022--RT-01Jun 24, 2022
What do you consider the biggest challenge that the pharma/biopharma industry currently faces?
Industry Challenges

What do you consider the biggest challenge that the pharma/biopharma industry currently faces?

Pharma's Almanac

O-06-022--RT-01Jun 24, 2022
Agilent Technologies, Inc
Immuno-Oncology

Agilent Announces Update on PD-L1 CE-IVD in Urothelial Carcinoma

Agilent Technologies, Inc

PR-M08-18-NI-082Aug 21, 2018
Agilent Technologies, Inc
Acquisition

Agilent Technologies Completes Acquisition of Advanced Analytical Technologies, Inc.

Agilent Technologies, Inc

PR-M06-18-NI-023Jun 07, 2018
Agilent Technologies, Inc
Partnership

Agilent Partners with Science Exchange

Agilent Technologies, Inc

PR-M02-18-NI-009Feb 02, 2018
Agilent Acquires Cobalt, a Raman Innovator
Acquisition

Agilent Acquires Cobalt, a Raman Innovator

Steve Kuehn

Nice Insight

PAO-M07-17-NI-013Jul 11, 2017
1 / 1